This task is about creating an unanswerable question based on a given passage. Construct a question that looks relevant to the given context but is unanswerable. Following are a few suggestions about how to create unanswerable questions:
(i) create questions which require satisfying a constraint that is not mentioned in the passage
(ii) create questions which require information beyond what is provided in the passage in order to answer
(iii) replace an existing entity, number, date mentioned in the passage with other entity, number, date and use it in the question
(iv) create a question which is answerable from the passage and then replace one or two words by their antonyms or insert/remove negation words to make it unanswerable.

Example Input: Passage: LE: Life expectancy at birth
MYS: Mean years of schooling (Years that a person 25 years-of-age or older has spent in schools)
EYS: Expected years of schooling (Years that a 5-year-old child will spend in schools throughout his life)
GNIpc: Gross national income at purchasing power parity per capita
Example Output: What does LI stand for?

Example Input: Passage: Mastic asphalt is a type of asphalt which differs from dense graded asphalt (asphalt concrete) in that it has a higher asphalt/bitumen (binder) content, usually around 7–10% of the whole aggregate mix, as opposed to rolled asphalt concrete, which has only around 5% added asphalt/bitumen. This thermoplastic substance is widely used in the building industry for waterproofing flat roofs and tanking underground. Mastic asphalt is heated to a temperature of 210 °C (410 °F) and is spread in layers to form an impervious barrier about 20 millimeters (0.79 inches) thick.
Example Output: What percentage of concrete is in mastic asphalt?

Example Input: Passage: Some of these estimates also take into account the opportunity cost of investing capital many years before revenues are realized (see Time-value of money). Because of the very long time needed for discovery, development, and approval of pharmaceuticals, these costs can accumulate to nearly half the total expense. A direct consequence within the pharmaceutical industry value chain is that major pharmaceutical multinationals tend to increasingly outsource risks related to fundamental research, which somewhat reshapes the industry ecosystem with biotechnology companies playing an increasingly important role, and overall strategies being redefined accordingly. Some approved drugs, such as those based on re-formulation of an existing active ingredient (also referred to as Line-extensions) are much less expensive to develop.
Example Output:
What drugs are the least fundamental to develop?